does semaglutide cause breast cancer The Impact and Safety of GLP‐1 Agents and Can you take Wegovy after

No existe una respuesta nica que aplique a todos los agonistas del receptor GLP-1, ya que cada frmaco tiene caractersticas farmacocinticas distintas

CagriSema trial dosing only, with no approved label

These medications (including semaglutide, dulaglutide, and liraglutide) are typically considered when: Metformin and other oral medications have not achieved adequate glycaemic control The patient has a BMI 35 kg/m (or lower thresholds, typically by around 2.5 kg/m, for people of certain ethnic backgrounds including South Asian) Weight loss would benefit other obesity-related comorbidities Insulin therapy is being considered but would have significant occupational implications or weight gain is a concern Continuation criteria apply: for example, treatment should reduce HbA1c by at least 11 mmol/mol (1.0%) and weight by at least 3% at 6 months to be continued

doi: 10.1016/j.neuroscience.2006.08.082 10 BannisterA